Related by context. All words. (Click for frequent words.) 78 MyVax ® 76 MyVax R 72 Arcelis ™ 72 IMA# 72 Personalized Immunotherapy 71 targeted radiotherapeutic 70 Onconase 69 Tarvacin TM 69 OvaRex R 69 CYT# potent vascular disrupting 69 Factor VIIa 69 lumiliximab 69 liposomal formulation 69 Panzem R NCD 69 Insegia 68 Allovectin 7 68 pharmacological chaperone 68 Vivecon 68 Phase IIb clinical trials 68 isoform selective 68 TOCOSOL Camptothecin 68 radiation sensitizer 68 investigational humanized monoclonal antibody 68 triphendiol 68 Xanafide 68 molecular imaging radiopharmaceutical 68 MEK inhibitors 68 JAK inhibitor 68 TOCOSOL 68 VitiGam 68 DPX Survivac 68 therapeutic monoclonal antibody 68 midstage trials 67 IAP inhibitor 67 Proxinium TM 67 IRX 2 67 TPI ASM8 67 OMP #M# 67 HCV protease inhibitors 67 THR beta agonist 67 Panzem 67 oral prodrug 67 Phase #b/#a clinical 67 non nucleoside 67 mitogen activated ERK kinase 67 Panzem NCD 67 Panzem R 67 IGF 1R inhibitor 67 MAGE A3 ASCI 67 histone deacetylase inhibitor 67 depsipeptide 67 Urocidin 67 HuLuc# 67 Hedgehog inhibitor 67 TLR9 agonist 67 anticancer therapeutics 67 compound ISA# 67 LymphoStat B TM 67 alvespimycin 67 Vascular Wrap TM 67 drug ISA# 67 PORxin TM 67 Marqibo TM 67 Annamycin 67 GVAX ® 67 OMAPRO 67 EndoTAG TM 67 predictive biomarkers 67 Virulizin ® 67 Archexin 67 lintuzumab SGN 67 novel therapeutic antibodies 67 PRT# 67 Locked Nucleic Acid LNA 67 preclinically 67 DXL# 66 bevacizumab Avastin ® 66 ATL# [001] 66 vidofludimus 66 cancer immunotherapies 66 RhuDex ® 66 immunotherapeutic vaccine 66 acyclovir Lauriad R 66 acetonide FA 66 Onalta ™ 66 HQK 66 mertansine 66 Ceflatonin 66 Zemiva TM 66 OncoVEX GM CSF 66 XmAb 66 lapatinib Tykerb 66 Thiovir 66 Telatinib 66 OncoVEX 66 proteasome inhibitor 66 JAK2 inhibitor 66 Aviptadil 66 immunomodulatory therapy 66 candidate deforolimus 66 humanized monoclonal antibodies 66 Fodosine 66 OHR/AVR# 66 humanized antibody 66 GW# [003] 66 volociximab 66 histamine dihydrochloride 66 PDX pralatrexate 66 PHX# 66 Gleevec resistant 66 drug GAP #B# 66 EndoTAG 66 apricitabine ATC 66 AQ4N 66 Xcytrin R 66 Intravenous CP 66 vascular disrupting agents 66 drug conjugate 66 dasatinib Sprycel 66 obatoclax 66 Pertuzumab 66 exon skipping 66 Arcelis TM 66 otelixizumab 66 novel peptide 66 Davanat 66 Daclizumab 66 immatics 66 ENMD # 66 FOLOTYN ® 66 GRNVAC1 66 tanespimycin 66 PDE4 inhibitor 66 Aplidin 66 Pradefovir 66 hypoxia activated prodrug 66 oral antiviral 66 AAG geldanamycin analog 66 Campath alemtuzumab 66 TBC# 66 kidney urologic 66 HuMax TAC 66 immunotherapeutic 66 ALN TTR# 66 EndoTAG TM -1 66 multicenter Phase II 66 phase IIb clinical 66 forodesine 65 DCVax R 65 metaglidasen 65 personalized dendritic 65 Solazed 65 Fx #A 65 tranilast 65 orally bioavailable 65 Triapine 65 vascular disrupting agent 65 oral ridaforolimus 65 refractory chronic lymphocytic 65 BRAF inhibitor 65 Pimavanserin 65 LymphoStat B belimumab 65 CDP# 65 receptor tyrosine kinase inhibitor 65 reslizumab 65 novel immunotherapies 65 MAXY G# 65 alkylating agent 65 GLP toxicology studies 65 OvaRex 65 selective immunoproteasome inhibitor 65 DOS# 65 p# inhibitor 65 thalidomide Thalomid 65 vinca alkaloid 65 PEGylated interferon 65 NP2 Enkephalin 65 anti CD3 monoclonal 65 immunotherapeutics 65 monoclonal antibody therapeutics 65 candidate TNFerade biologic 65 Fc fusion protein 65 siRNA therapeutics 65 oncolytic virus therapies 65 nucleoside analog 65 gemcitabine Gemzar ® 65 BrachySil TM 65 SinuNase ™ 65 YONDELIS 65 Angiocept 65 MyVax 65 generation purine nucleoside 65 antibody MAb 65 VitiGam TM 65 Trofex 65 TKM ApoB 65 Iluvien ® 65 theranostic 65 successfully commercialize Iluvien 65 ALN PCS 65 AKT inhibitor 65 Initiate Clinical Trial 65 Abiraterone acetate 65 Provecta TM 65 PrevOnco 65 targeting CD# 65 investigational immunotherapy 65 orBec 65 Myocet 65 Amigal 65 velafermin 65 anti infective treatments 65 chimeric monoclonal antibody 65 DermaVir Patch 65 TRO# 65 L BLP# 65 omacetaxine mepesuccinate 65 Ixempra 65 Neuvenge 65 Cimzia TM 65 IMC #B 65 OncoVex 65 relapsed leukemia 65 IgG1 antibody 65 loaded dendritic cell 65 Interferon beta 65 Anidulafungin 65 CINTREDEKIN BESUDOTOX 65 small molecule activators 65 phosphatidylserine PS targeting 65 polysaccharide polymer 65 registrational trial 65 agent VDA 65 CTAP# Capsules 65 oral picoplatin 65 mda 7 65 PARP inhibitor 65 kinase inhibition 65 pharmacokinetic PK study 65 BiovaxID TM 65 MEK inhibitor RDEA# 65 BCG refractory 65 Pyridorin 65 TransVax tm 65 Tyrima 65 deforolimus 64 NEUGENE 64 sodium glucose transporter 64 Altastaph 64 Alfacell proprietary ribonuclease 64 ganetespib 64 MAXY VII 64 Octreotide 64 Preclinical studies suggest 64 Celator 64 IAP inhibitors 64 investigational therapies 64 OvaRex ® MAb 64 Vaxfectin TM 64 Bezielle 64 Allovectin 7 R 64 oral taxane 64 vaccines oncolytic virus 64 EOquin TM 64 DepoVax TM 64 Aflibercept 64 Aurora kinase inhibitor 64 ocular formulation 64 subcutaneous formulation 64 NEUGENE antisense 64 antisense drug 64 Civacir 64 novel anticancer 64 Spiegelmer ® 64 HuMax CD4 64 introduced NEUGENE 64 anti angiogenic agents 64 Locked Nucleic Acid 64 AEG# 64 cellular immunotherapy 64 targeted antifolate 64 Gleevec imatinib mesylate 64 KRAS mutant 64 A3 adenosine receptor 64 Cx# [002] 64 investigational monoclonal antibody 64 LHRH antagonists 64 nucleotide analog 64 REOLYSIN ® 64 ProMune 64 CCR5 antagonist 64 vosaroxin 64 PI3K/Akt pathway inhibitor 64 cMET 64 Panzem ® 64 Kosan dependence 64 immune modulating 64 Hemopurifier ® 64 regorafenib 64 Immunotherapeutic 64 CCR5 mAb 64 eTag assays 64 intranasal insulin product 64 Cloretazine 64 tafamidis 64 BiTE antibody 64 Generx ™ 64 inhaled AAT 64 SUTENT ® 64 HSP# inhibitor 64 NV1FGF 64 anti CD3 64 endothelin antagonist 64 Potelligent Technology 64 Viramidine 64 ATIR 64 Etubics 64 G#DT 64 imatinib Gleevec ® 64 HyACT 64 ASONEP 64 Lixivaptan 64 Troxatyl 64 IgG1 monoclonal antibody 64 2 methoxyestradiol 64 Vicinium TM 64 thetreatment 64 liposomal delivery 64 novel emulsion formulation 64 antisense inhibitors 64 Phase Ib clinical 64 ZK EPO 64 SinuNase TM 64 BrachySil 64 DNA methylation biomarkers 64 immunological diseases 64 Micromet BiTE 64 MVA BN R 64 RNAi therapeutic targeting 64 telomerase inhibitor 64 pain palliation 64 PNP inhibitor 64 anticancer compound 64 Azedra 64 demethylating agent 64 non nucleoside inhibitor 64 radiotherapeutic 64 tiapamil 64 HspE7 64 oncolytic virus therapy 64 Chimigen TM 64 PSMA ADC 64 therapeutic monoclonal antibodies 64 Hsp# inhibition 64 ELACYT 64 CRD5 64 UPLYSO 64 HuMax EGFr 64 beta 1a 64 Troxatyl TM 64 Hsp# Inhibitor 64 dasatinib Sprycel ® 64 Revlimid lenalidomide 64 pertuzumab 64 anticancer therapies 64 dacetuzumab 64 Sphingomab TM 64 relapsed ovarian cancer 64 AVI NEUGENE 64 novel L DOS# 64 TELINTRA 64 KIACTA ™ 64 evaluating tivozanib 64 Rituxan rituximab 64 MGd 64 intranasal formulation 64 AzaSite Plus 64 Copegus ribavirin 64 PANVAC VF 64 SIR Spheres 64 Endotis 64 HyperAcute 64 bortezomib Velcade 64 Oasmia 64 Allovectin 7 ® 64 Irinotecan 64 Bellicum 64 Tarmogen 64 erlotinib Tarceva ® 64 TOCOSOL Paclitaxel 64 Cardio Vascu Grow 64 recombinant antibodies 64 Modrenal 63 Genentech Rituxan 63 aerosolized KL4 surfactant 63 CCR9 antagonist 63 Taxotere chemotherapy 63 IMiD 63 Ceplene TM 63 multiple myeloma MM 63 LEP ETU 63 Nektar proprietary 63 CRMD# 63 GPR# agonist 63 elacytarabine 63 AMPK activators 63 molecularly targeted 63 XmAb ™ 63 selective kinase inhibitor 63 Eribulin 63 rxRNA 63 selective adenosine 63 BiTE 63 gefitinib Iressa 63 phase IIb trial 63 trastuzumab DM1 T DM1 63 XP# XP# 63 Oral NKTR 63 alemtuzumab Campath 63 HGS ETR1 mapatumumab 63 Nexavar sorafenib 63 epigenetic therapies 63 ALN TTR 63 Phase Ib study 63 Alzhemed TM 63 trastuzumab Herceptin R 63 acadesine 63 atacicept 63 Genentech Herceptin 63 oral talactoferrin 63 delipidation 63 GED aPC 63 Onco TCS 63 BRAF inhibitors 63 HGS ETR2 63 Fludara ® 63 Dacogen decitabine 63 KRN# 63 CEQ# 63 elotuzumab 63 cediranib 63 Uvidem 63 cannabinor 63 product Fentanyl TAIFUN 63 anti CD3 antibody 63 NPC 1C 63 Exelixis compounds 63 Telintra 63 aurora kinase 63 tolevamer 63 ARIKACE ™ 63 Reports Preclinical Data 63 CRLX# 63 corticosteroid dexamethasone 63 Surfaxin LS 63 Cloretazine ® 63 NEUGENE R 63 HGS# 63 docetaxel Taxotere R 63 PLK1 SNALP 63 anticoagulant reversing agent 63 anti CD# antibodies 63 R sorafenib tablets 63 Apoptone 63 Allovectin 7 r 63 ghrelin antagonist 63 CCR5 inhibitors 63 humanized anti 63 MEK inhibitor 63 Quinamed 63 TMC# [002] 63 FluCide 63 ONCONASE R 63 incyclinide 63 RIGScan CR 63 Tykerb lapatinib 63 immunotherapeutic approaches 63 Amrubicin 63 Vaccinex 63 TRIST study 63 orally dosed 63 castrate resistant prostate cancer 63 Alferon N 63 tramiprosate Alzhemed TM 63 therapeutic peptide 63 sunitinib malate 63 monoclonal antibody MAb 63 DCVax 63 recombinant biopharmaceutical 63 humanized monoclonal antibody 63 inhibit metastasis 63 humanised monoclonal antibody 63 Mpex 63 TroVax ® 63 non nucleoside HCV 63 Novolimus 63 M# rationally 63 TLR8 agonist 63 MKC# MT 63 faropenem 63 Corgentin 63 Symadex 63 KL4 surfactant 63 afamelanotide 63 essential thrombocythemia ET 63 JAK inhibitors 63 PEGylated interferon beta 1a 63 Campath ® 63 JAK1 63 Neuradiab 63 CBLC# 63 Bioral 63 elvucitabine 63 NuMimetic TM 63 intranasal delivery 63 #D#C# 63 LibiGel ® 63 multi kinase inhibitor 63 peptidomimetic 63 GMX# 63 small molecule tyrosine 63 epothilone 63 HDL Mimetic Peptide 63 rNAPc2 63 farletuzumab 63 Squalamine 63 including eniluracil ADH 63 Olaparib 63 5 fluorouracil leucovorin 63 oncolytic 63 synthetic retinoid 63 SuperAntibody 63 TG# [003] 63 PROVENGE ® 63 RH1 63 phase IIa clinical 63 Dendreon investigational 63 PTK# 63 siRNA therapeutic 63 Isis antisense 63 vemurafenib 63 Zybrestat 63 SMaRT ™ 63 oral Factor Xa 63 oncolytic virus 63 Targeted Chemotherapy 63 PrevOnco ™ 63 Phase #b/#a trial 63 Opterone R 63 Neovastat 63 CA9 SCAN 63 Exherin TM 63 ospemifene 63 Pazopanib 63 PSN# [001] 63 Initiates Enrollment 63 omega interferon 63 Sebivo 63 dirucotide MBP# 63 Neugene 63 TRX1 63 investigational HCV polymerase 63 progressive metastatic prostate 63 ADP receptor antagonist 63 inhibitor RG# 63 recombinant interferon 63 mTOR inhibitor 63 immuno therapeutic 63 Soliris eculizumab 63 CYT# vascular disrupting 63 NEUMUNE 63 fluoropyrimidine 63 allogeneic cell 63 Silodosin 63 HuCNS SC ® 63 MyVax personalized immunotherapy 63 liposomal doxorubicin 63 PF # [002] 63 tubulin inhibitor 63 Azacitidine 63 potent suppressor 63 Cancidas 63 Angiolix 63 PEG SN# 63 demonstrated antitumor activity 63 etanercept Enbrel 63 metastatic colorectal 63 JAK2 inhibitors 63 tremelimumab 63 treat chronic sinusitis 63 Intarcia 63 targets Galectin receptors 63 antiangiogenic agent 63 Theratope 63 neratinib 63 Janus Kinase 63 XL# anticancer compounds 63 PNT# 63 Genitope Corporation 63 selective estrogen receptor modulator 63 ALN HTT 63 Mipomersen 63 Locteron ® 63 CD# monoclonal antibody 63 IMiDs ® compound 63 novel VDA molecule 63 Cytolin R 63 entinostat 63 ZFP Therapeutics 63 Lupuzor 63 nanoviricides 63 cetuximab Erbitux R 63 Temsirolimus 63 RhuDex TM 63 CR# vcMMAE 63 RAV# 63 Vidaza azacitidine 63 ReN# 62 TLK# 62 HGS ETR1 62 MVA BN 62 Asentar 62 dirucotide 62 trastuzumab DM1 62 Presents Preclinical Data 62 bendamustine 62 paclitaxel poliglumex 62 Curaxin CBLC# 62 axitinib 62 DEEP AF 62 Ceflatonin R 62 humanized antibodies 62 polycythemia vera essential thrombocythemia 62 HuCAL antibodies 62 Pervasis 62 trabectedin 62 AzaSite Xtra 62 RNA antagonists 62 mTOR inhibition 62 novel immunomodulatory 62 preclinical efficacy 62 ThermoDox ® clinical 62 Vinorelbine 62 novel antiviral therapeutics 62 seliciclib CYC# 62 pediatric acute lymphoblastic 62 ZACTIMA 62 gemcitabine Gemzar 62 brostallicin 62 potently inhibit 62 EndoTAGTM 1 62 Curaxin 62 immunosuppressant therapies 62 Phase IIb trials 62 Xcellerated T Cells 62 Genasense ® 62 personalized dendritic cell 62 molecular chaperone regulation 62 Fleximer 62 AAV vectors 62 ruxolitinib 62 DNA intercalator 62 favorable pharmacokinetic profile 62 selective orally bioavailable 62 Memryte 62 paclitaxel Taxol ® 62 NurOwn 62 Oxaliplatin 62 ALK inhibitors 62 hormone LHRH antagonist 62 aldehyde dehydrogenase ALDH2 deficiency 62 samalizumab 62 XL# XL# 62 PEP# [003] 62 DCVax ® Brain 62 PEGPH# 62 VivaGel ™ 62 Phase 2a trial 62 novel oral anticoagulant 62 CD# CEA 62 sorafenib Nexavar 62 Clolar ® 62 motexafin gadolinium Injection 62 sd rxRNA 62 accumulate preferentially 62 aerosolized AAT 62 MGN# 62 virosome 62 HTS assay 62 systemically administered 62 candidate MyVax 62 lintuzumab 62 Dacogen injection 62 ® bortezomib 62 TLR agonists 62 DermaVir 62 muscarinic receptor agonist 62 personalized cellular immunotherapy 62 HepDirect R 62 HCV protease inhibitor 62 eniluracil 62 Anticalin R 62 virus HCV protease inhibitor 62 Firazyr 62 Solazed TM 62 assessing T DM1 62 levoleucovorin 62 EGFR HER 62 RenaZorb 62 Glufosfamide 62 torezolid phosphate 62 vapreotide acetate 62 telomerase therapeutic 62 NovaBay Aganocide compounds 62 Tumour Vascular Disrupting Agent 62 AGS PSCA 62 BIM #A# 62 StemEx R 62 ATL# [002] 62 lentiviral vector 62 Sudhir Agrawal D.Phil 62 amrubicin 62 Novavax VLP vaccine 62 evaluating picoplatin 62 oxypurinol 62 Trastuzumab DM1 62 Canvaxin TM 62 Specifid 62 Spiegelmer 62 Prednisporin TM 62 TKI therapy 62 tivozanib 62 paclitaxel Taxol 62 vinorelbine tartrate 62 DEB# 62 INCB# [001] 62 Nanobody 62 IMP# 62 Degarelix 62 Pharmacokinetics PK 62 BrachySil ™ 62 therapeutic regimens 62 cisplatin carboplatin 62 HepeX B 62 MORAb 62 Mepact 62 P#X# antagonist 62 lorvotuzumab mertansine 62 novel immunotherapeutic 62 sorafenib tablets 62 Anticalins ® 62 CMV vaccine 62 TRAIL receptor antibodies 62 alemtuzumab MS 62 ganaxolone 62 Achieves Primary Endpoint 62 Omacetaxine 62 Syntonix 62 GAP #B# 62 HCV antiviral 62 novel synthetic peptide 62 Genz # 62 Phase #/#a trial 62 NS5B polymerase 62 signal transduction inhibitor 62 immunoconjugate 62 Chemokine Therapeutics 62 TAT# 62 CCR5 inhibitor 62 relapsed multiple myeloma 62 nilotinib Tasigna 62 MT# MEDI 62 bardoxolone 62 Inc. AMEX YMI 62 glucokinase activator 62 Aegera 62 Evoltra ® 62 fusion enhancers 62 Iluvien TM 62 tezampanel NGX# 62 MAXY alpha 62 Aganocide 62 liposomal ciprofloxacin 62 ocrelizumab 62 REMUNE R 62 stable nucleic acid 62 ESBA# 62 immunotherapy 62 Manja Bouman CEO 62 orally administered inhibitor 62 SMT C# 62 AdhTAP 62 Zenvia ™ 62 Xeloda ® 62 candidate epratuzumab 62 LEAPS TM 62 Excellagen 62 Cinryze ™ 62 Pruvel 62 Fibroblast Growth Factor Receptor 62 Liprotamase 62 TELCYTA 62 relapsing multiple sclerosis 62 DepoVax ™ vaccine 62 HCD# [002] 62 eprotirome 62 Nanobody ® 62 HCV polymerase 62 Peginterferon alfa 2b 62 plasma kallikrein inhibitor 62 rolapitant 62 Thiarabine 62 ALV# 62 HDL Selective Delipidation 62 SERMs 62 immunosuppressive regimens 62 protein kinase inhibitor 62 SYN# 62 SCIB1 62 Phase Ib clinical trials 62 Cloretazine R 62 VIR# 62 novel antibody therapeutics 62 Linjeta TM 62 adecatumumab MT# 62 RIGScan 62 CRTH2 62 Combidex 62 rALLy clinical trial 62 systemic RNAi therapeutic 62 OMNARIS HFA 62 Canvaxin 62 docetaxel Taxotere ® 62 topically applied SEPA 62 Alocrest 62 Simulect 62 oncolytic viruses 62 human IgG1 monoclonal 62 Bioral Amphotericin B. 62 LEX System 62 Clavis Pharma 62 platforms GVAX 62 gemcitabine cisplatin 62 IV Busulfex 62 riociguat 62 monoclonal antibody therapies 62 thymalfasin 62 Chimigen 62 treating neuropathic pain 62 Linjeta ™ 62 Cylene 62 dutogliptin 62 myelofibrosis polycythemia vera 62 SPRYCEL ® 62 MT#/MEDI-# 62 haematological cancers 62 FVIIa 62 CDK inhibitor 62 PORxin 62 Phase Ib II 62 CytoSorb TM 62 Tesetaxel 62 Lisofylline 62 immunotherapeutic agent 62 ISF# 62 Onalta 62 Guanilib 62 tyrosine kinase inhibitor 62 lucinactant 62 CCX# 62 IL# PE#QQR 62 Maxy G# 62 Generx TM 62 zanolimumab 62 LEVADEX ™ 62 NeoLipid TM 62 Prodarsan R 62 anidulafungin 62 AFFITOME R 62 delay bone metastases 62 BNC# 62 highly selective inhibitor 62 IMiDs R 62 Genasense ® oblimersen 62 Luteinizing Hormone Releasing Hormone 62 CYC# 62 RLY# 62 docetaxel Taxotere 62 BEMA Granisetron 62 CAMPATH 62 candidates Azedra TM 62 candidate AQ4N 62 recurrent metastatic 62 custirsen 62 Syncria 62 immunotherapy treatments 62 systemic RNAi 62 myeloproliferative disorders 62 relapsing remitting MS RRMS 62 S/GSK# 61 delta isoform 61 Anavex #-# 61 XYOTAX TM 61 exemestane Aromasin 61 BEMA TM Fentanyl 61 Vaxfectin 61 VEGF inhibitor 61 recurrent metastatic ovarian cancer 61 IMPDH inhibitor 61 FOLFOX chemotherapy 61 novel prodrug 61 chemotherapy induced neutropenia 61 Tocosol Paclitaxel 61 biomarker assays 61 Phase 2a clinical trials 61 Tarvacin 61 anti EGFR antibody 61 FOLFOX6 chemotherapy regimen 61 Chemophase 61 Ozarelix 61 renin inhibition 61 humanized monoclonal 61 cilengitide 61 histone deacetylase HDAC inhibitor 61 investigational integrase inhibitor 61 LE SN# 61 albumin bound paclitaxel 61 ONCASPAR 61 drug zotarolimus 61 ProLindac TM 61 Excellarate 61 Seliciclib 61 LHRH antagonist 61 iclaprim 61 AZILECT ® 61 Anticalin 61 visilizumab 61 CA4P 61 SNT MC# 61 HuMax 61 Neulasta R 61 lenalidomide Revlimid 61 pomalidomide 61 Shigamabs R 61 MET inhibitor 61 Voraxaze 61 Vitaxin 61 cystinosis patients 61 ProSavin 61 Liposomal 61 GLP1 INT TM 61 photodisinfection 61 JVRS 61 investigational hepatitis C 61 proprietary PEGylation 61 darinaparsin ZIO 61 MET amplification 61 Aerosurf 61 Azedra TM 61 OnDose 61 Ketotransdel 61 LEUKINE 61 molecular biomarkers 61 adecatumumab 61 YONDELIS R 61 CVac 61 Phase IIb III 61 Vidaza R 61 Micromet proprietary BiTE 61 Xelox 61 VNP#M 61 Afatinib 61 Tofacitinib 61 tumor vascular disrupting 61 histone deacetylase HDAC 61 diarrhea predominant irritable 61 Interferon alpha 61 Amplimexon 61 patented Bioral 61 Nanobody R 61 Shigamabs ® 61 antiangiogenesis 61 Phase 1b clinical trials 61 oral deforolimus 61 KL4 Surfactant 61 Phase #b/#a 61 TRIOLEX HE# APOPTONE HE# 61 cintredekin besudotox 61 Hedgehog Pathway Inhibitor 61 MOVIPREP R 61 HCV polymerase inhibitor 61 NS5b 61 ATL/TV# 61 dexpramipexole 61 molecular chaperone 61 CytoFabTM 61 epithelial tumors 61 multitargeted 61 Ampligen ®